Frazier Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$110K Hold
1,278
– – 0.05% 131
2026
Q2
$116K Hold
1,278
– – 0.06% 112
2026
Q1
$102K Sell
1,278
-124
-9% -$10.2K 0.06% 115
2025
Q4
$120K Buy
1,402
+124
+10% +$10.2K 0.07% 95
2025
Q3
$99.4K Hold
1,278
– – 0.06% 102
2025
Q2
$100K Sell
1,278
-24
-2% -$1.79K 0.07% 99
2025
Q1
$94.4K Hold
1,302
– – 0.07% 90
2024
Q4
$96.7K Buy
1,302
+30
+2% +$2.1K 0.08% 87
2024
Q3
$83.9K Hold
1,272
– – 0.07% 101
2024
Q2
$117K Sell
1,272
-43
-3% -$3.81K 0.09% 88
2024
Q1
$126K Sell
1,315
-115
-8% -$9.7K 0.1% 85
2023
Q4
$109K Buy
+1,430
New +$100K 0.09% 82

Other funds holding EW

Frazier Financial Advisors's EW Position: Q3 2026 in Review

Frazier Financial Advisors held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,278 shares worth $110K. The position accounts for 0.05% of the portfolio, ranked #131.

Frazier Financial Advisors first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $126K in Q1 2024. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Frazier Financial Advisors held 1,278 shares of Edwards Lifesciences worth $110K as of Q3 2026.
  • Frazier Financial Advisors left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.05% of Frazier Financial Advisors's portfolio in Q3 2026, its #131 holding.
  • Frazier Financial Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
  • Frazier Financial Advisors's Edwards Lifesciences position peaked at $126K in Q1 2024.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.